Skip to search formSkip to main contentSkip to account menu

PF 610355

Known as: PF-610355, PF610355 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Эффективность и безопасность агонистов #b2-адренорецепторов ультрадлительного действия
Beta-2-adrenoreceptor agonists (#b 2 -АA) are one of the key drugs used for treatment of chronic obstructive pulmonary disease… 
Review
2011
Review
2011
β2‐adrenoceptor agonists: current and future direction
Despite the passionate debate over the use of β2‐adrenoceptor agonists in the treatment of airway disorders, these agents are… 
Highly Cited
2010
Highly Cited
2010
Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist…
A novel series of potent and selective sulfonamide derived β(2)-adrenoreceptor agonists are described that exhibit potential as… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License